Sequential treatment with IVIg and cyclosporin may be effective for refractory chronic bilateral pleural effusions associated with autoimmune features.
May support sequential IVIg-cyclosporin for refractory autoimmune pleural effusions; hypothesis-generating and requires prospective validation.
A 48 y old woman with unremarkable medical history was admitted with bilateral pleural effusions; even though the fluid was drained, it re-accumulated and necessitated many repeated drainages in the following 2.5 y (56 hospitalisations). The patient underwent an extensive diagnostic work-up that disclosed elevated serum antinuclear antibodies, serum anti-dsDNA antibodies, pleural fluid anti-dsDNA and decreased pleural fluid C3 and C4. During that period she has been treated with a variety of immunomodulating agents, several pleural talcage and pleurectomy, without any apparent response. Thereafter, she received six courses of IVIg (2 g/kg body weight) in monthly intervals, followed by four months treatment with cyclosporin. This treatment resulted in gradual and eventually complete disappearance of the pleural effusion, and now after more than 2 y the patient is free of symptoms and receives no further medications.
No takes yet. Share an insight, caveat, or question.
Sherer et al. (1999) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: